Ovid Therapeutics Stock Market Value
| OVID Stock | USD 1.56 0.01 0.65% |
| Symbol | Ovid |
Will Biotechnology sector continue expanding? Could Ovid diversify its offerings? Factors like these will boost the valuation of Ovid Therapeutics. Anticipated expansion of Ovid directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Ovid Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.50) | Revenue Per Share | Quarterly Revenue Growth (0.24) | Return On Assets | Return On Equity |
Ovid Therapeutics's market price often diverges from its book value, the accounting figure shown on Ovid's balance sheet. Smart investors calculate Ovid Therapeutics' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Ovid Therapeutics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Ovid Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ovid Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Ovid Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Ovid Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ovid Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ovid Therapeutics.
| 11/01/2025 |
| 01/30/2026 |
If you would invest 0.00 in Ovid Therapeutics on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding Ovid Therapeutics or generate 0.0% return on investment in Ovid Therapeutics over 90 days. Ovid Therapeutics is related to or competes with Context Therapeutics, MacroGenics, Clene, Oramed Pharmaceuticals, Shattuck Labs, ImageneBio, and Connect Biopharma. Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurolo... More
Ovid Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ovid Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ovid Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.47 | |||
| Information Ratio | 0.0054 | |||
| Maximum Drawdown | 36.13 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 9.2 |
Ovid Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ovid Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ovid Therapeutics' standard deviation. In reality, there are many statistical measures that can use Ovid Therapeutics historical prices to predict the future Ovid Therapeutics' volatility.| Risk Adjusted Performance | 0.0202 | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.34) | |||
| Sortino Ratio | 0.0058 | |||
| Treynor Ratio | 0.0351 |
Ovid Therapeutics January 30, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0202 | |||
| Market Risk Adjusted Performance | 0.0451 | |||
| Mean Deviation | 4.14 | |||
| Semi Deviation | 4.87 | |||
| Downside Deviation | 5.47 | |||
| Coefficient Of Variation | 6356.56 | |||
| Standard Deviation | 5.93 | |||
| Variance | 35.12 | |||
| Information Ratio | 0.0054 | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.34) | |||
| Sortino Ratio | 0.0058 | |||
| Treynor Ratio | 0.0351 | |||
| Maximum Drawdown | 36.13 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 9.2 | |||
| Downside Variance | 29.97 | |||
| Semi Variance | 23.73 | |||
| Expected Short fall | (5.35) | |||
| Skewness | 0.7001 | |||
| Kurtosis | 2.47 |
Ovid Therapeutics Backtested Returns
Ovid Therapeutics appears to be extremely dangerous, given 3 months investment horizon. Ovid Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0607, which implies the firm had a 0.0607 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Ovid Therapeutics, which you can use to evaluate the volatility of the company. Please evaluate Ovid Therapeutics' Risk Adjusted Performance of 0.0202, semi deviation of 4.87, and Coefficient Of Variation of 6356.56 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Ovid Therapeutics holds a performance score of 4. The company holds a Beta of 2.37, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ovid Therapeutics will likely underperform. Please check Ovid Therapeutics' total risk alpha, expected short fall, price action indicator, as well as the relationship between the value at risk and daily balance of power , to make a quick decision on whether Ovid Therapeutics' historical price patterns will revert.
Auto-correlation | -0.07 |
Very weak reverse predictability
Ovid Therapeutics has very weak reverse predictability. Overlapping area represents the amount of predictability between Ovid Therapeutics time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ovid Therapeutics price movement. The serial correlation of -0.07 indicates that barely 7.0% of current Ovid Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.07 | |
| Spearman Rank Test | -0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ovid Therapeutics is a strong investment it is important to analyze Ovid Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ovid Therapeutics' future performance. For an informed investment choice regarding Ovid Stock, refer to the following important reports:Check out Ovid Therapeutics Correlation, Ovid Therapeutics Volatility and Ovid Therapeutics Performance module to complement your research on Ovid Therapeutics. For information on how to trade Ovid Stock refer to our How to Trade Ovid Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Ovid Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.